Silvestris F, Cafforio P, Dammacco F
Department of Biomedical Sciences and Human Oncology, University of Bari Medical School, Italy.
Clin Exp Immunol. 1994 Jul;97(1):19-25. doi: 10.1111/j.1365-2249.1994.tb06573.x.
This study was addressed to explore the reactivity of natural anti-idiotypes from commercial lots of immunoglobulins to several idiotypes (Ids), usually expressed by anti-DNA molecules in lupus nephritis. Eleven intravenous immunoglobulin (IVIG) preparations and nine (three polyvalent and six hyper-immune) intramuscular IgG were investigated for specific content of anti-DNA, anti-F(ab')2 and antibodies reacting with several anti-DNA IgG Ids. Two samples (nos 6 and 11) showed high reactivity with allogeneic F(ab')2 and with F(ab')2 of myeloma proteins bearing the anti-DNA Id 3I+ and the 8.12+. Since both 3I and 8.12 Id markers are known to characterize pathogenic anti-DNA IgG in systemic lupus erythematosus (SLE), anti-Id antibodies to these markers were obtained by absorbing the IVIG samples nos 6 and 11 to Sepharose columns coupled with pooled F(ab')2 fragments of 3I(+)-F4(+)-8.12(+)-myeloma proteins. Inhibition experiments showed that anti-8.12 Id-eluted IgG induced a selective suppression of the DNA-reactive antibodies derived from patients with active lupus nephritis to their substrate, suggesting the involvement of 8.12+ molecules in the SLE glomerular damage. Since 8.12+ anti-DNA are nephritogenic antibodies, the occurrence of anti-8.12+ Id in commercial IVIG may be of potential therapeutic relevance in modulating the pathogenic SLE Id network. Previous variable results of IVIG treatment in SLE, such as resolution of proteinuria or worsening nephritis, could be related to variable enrichment of different lots of IVIG in suppressive anti-pathogenic Id antibodies.
本研究旨在探讨市售免疫球蛋白制剂中天然抗独特型抗体对几种独特型(Id)的反应性,这些独特型通常由狼疮性肾炎中抗DNA分子所表达。研究了11种静脉注射免疫球蛋白(IVIG)制剂和9种(3种多价和6种高免疫)肌肉注射IgG的抗DNA、抗F(ab')2以及与几种抗DNA IgG独特型反应的抗体的特定含量。两个样本(6号和11号)与同种异体F(ab')2以及带有抗DNA独特型3I+和8.12+的骨髓瘤蛋白的F(ab')2具有高反应性。由于已知3I和8.12独特型标记可表征系统性红斑狼疮(SLE)中致病性抗DNA IgG,通过将6号和11号IVIG样本吸附到与3I(+)-F4(+)-8.12(+)-骨髓瘤蛋白的混合F(ab')2片段偶联的琼脂糖柱上,获得了针对这些标记的抗独特型抗体。抑制实验表明,抗8.12独特型洗脱的IgG可选择性抑制活动性狼疮性肾炎患者来源的DNA反应性抗体与其底物的反应,提示8.12+分子参与了SLE肾小球损伤。由于8.12+抗DNA是致肾炎抗体,市售IVIG中抗8.12+独特型的出现可能在调节致病性SLE独特型网络方面具有潜在的治疗意义。既往IVIG治疗SLE的结果不一,如蛋白尿消退或肾炎恶化,可能与不同批次IVIG中抑制性抗致病性独特型抗体的不同富集程度有关。